Through our strategic partnership, we can leverage broader expertise and a global perspective. By partnering with GC Pharma and Mogam Biomedical Research Institute, we focus on preventing infectious diseases by bringing effective vaccines to market. Together, we can rapidly bring the latest technologies in vaccine science from the laboratory to the clinic.
Mogam Institute for Biomedical Research
As a nonprofit global research organization, MIBR (Mogam Institute for Biomedical Research) is engaged in basic discovery research to combat infectious diseases, cancer, and rare diseases. Founded in 1983, MIBR is headquartered in southern Seoul, with several research collaborations ongoing with GC Pharma. MOGAM Institute’s role in Curevo will provide expertise in the design and pre-clinical optimization of protein subunit vaccines.
GC Pharma
GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions for more than half a century. GC Pharma brings knowledge in manufacturing and process development of vaccine material for clinical studies and product development.
Synergy
Partnerships are powerful. Consider partnering with Curevo to stop the spread of infectious disease.
